Cargando…
Rationale of receptor-based antivirals against SARS
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149114/ http://dx.doi.org/10.2165/00128413-200313950-00004 |
_version_ | 1783520740362944512 |
---|---|
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7149114 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-71491142020-04-13 Rationale of receptor-based antivirals against SARS Inpharma Weekly Correspondence Springer International Publishing 2013-02-09 2003 /pmc/articles/PMC7149114/ http://dx.doi.org/10.2165/00128413-200313950-00004 Text en © Adis International Ltd 2003 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Correspondence Rationale of receptor-based antivirals against SARS |
title | Rationale of receptor-based antivirals against SARS |
title_full | Rationale of receptor-based antivirals against SARS |
title_fullStr | Rationale of receptor-based antivirals against SARS |
title_full_unstemmed | Rationale of receptor-based antivirals against SARS |
title_short | Rationale of receptor-based antivirals against SARS |
title_sort | rationale of receptor-based antivirals against sars |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149114/ http://dx.doi.org/10.2165/00128413-200313950-00004 |